CNBX Pharmaceuticals Inc.
corporate_fare Company Profile
CNBX Pharmaceuticals Inc. (OTC:CNBX) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 5 items for CNBX at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-10-01, rated 8/10. Across its 5 most recent items scored 7 or higher, the top rating is 9/10, with 4 rated 8 or above. Recent SEC coverage for CNBX spans 8-K, 10-Q.
Recent high-impact activity:
- CNBX Swaps Auditor for India-Based Firm as Going-Concern Doubts Loom
- CNBX Pharmaceuticals Reports Dire Financials, Massive Dilution, and Going Concern Warning
- CNBX Pharmaceuticals Reports Critical Liquidity Crisis, Going Concern Doubt, and Massive Dilution
- CNBX Pharmaceuticals Secures $45,000 Loan to Address Immediate Working Capital Needs
- CNBX Pharmaceuticals Reports Deepening Losses, Critical Cash Shortage, and Substantial Dilution Amid Going Concern Warning
Financial Snapshot
Short Interest & Short Volume
1.00 days to coverFINRA reported short interest of 160,001 shares in CNBX as of the October 30, 2026 settlement, a 16000000.0% increase from the prior period — about 1.0 days to cover at its recent average daily volume. On November 20, 2026, 4.4% of CNBX volume reported to FINRA trade-reporting facilities was marked short.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.